SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-102323
Filing Date
2021-03-31
Accepted
2021-03-31 16:30:38
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d129601ds3.htm S-3 357621
2 EX-1.2 d129601dex12.htm EX-1.2 210317
3 EX-4.2 d129601dex42.htm EX-4.2 283062
4 EX-5.1 d129601dex51.htm EX-5.1 23566
5 EX-5.2 d129601dex52.htm EX-5.2 13374
6 EX-23.2 d129601dex232.htm EX-23.2 1928
7 GRAPHIC g129601dsp153.jpg GRAPHIC 3223
8 GRAPHIC g129601dsp154.jpg GRAPHIC 5032
9 GRAPHIC g129601dsp155.jpg GRAPHIC 2569
10 GRAPHIC g129601g62t48.jpg GRAPHIC 32833
  Complete submission text file 0001193125-21-102323.txt   945523
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254918 | Film No.: 21793833
SIC: 3841 Surgical & Medical Instruments & Apparatus